295 related articles for article (PubMed ID: 26979107)
1. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Hijaz M; Das S; Mert I; Gupta A; Al-Wahab Z; Tebbe C; Dar S; Chhina J; Giri S; Munkarah A; Seal S; Rattan R
BMC Cancer; 2016 Mar; 16():220. PubMed ID: 26979107
[TBL] [Abstract][Full Text] [Related]
2. Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
Giri S; Karakoti A; Graham RP; Maguire JL; Reilly CM; Seal S; Rattan R; Shridhar V
PLoS One; 2013; 8(1):e54578. PubMed ID: 23382918
[TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery and Redox Activity of Folic Acid-Functionalized Nanoceria in Tumor Cells.
Vassie JA; Whitelock JM; Lord MS
Mol Pharm; 2018 Mar; 15(3):994-1004. PubMed ID: 29397735
[TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Natali PG; Bagnato A
Can J Physiol Pharmacol; 2010 Jun; 88(6):676-81. PubMed ID: 20628434
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
9. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
10. Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo.
Liu Y; Chen S; Sun J; Zhu S; Chen C; Xie W; Zheng J; Zhu Y; Xiao L; Hao L; Wang Z; Chang S
Mol Pharm; 2019 Oct; 16(10):4104-4120. PubMed ID: 31517495
[TBL] [Abstract][Full Text] [Related]
11. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
Mabuchi S; Terai Y; Morishige K; Tanabe-Kimura A; Sasaki H; Kanemura M; Tsunetoh S; Tanaka Y; Sakata M; Burger RA; Kimura T; Ohmichi M
Clin Cancer Res; 2008 Dec; 14(23):7781-9. PubMed ID: 19047105
[TBL] [Abstract][Full Text] [Related]
12. Endocytosis of cerium oxide nanoparticles and modulation of reactive oxygen species in human ovarian and colon cancer cells.
Vassie JA; Whitelock JM; Lord MS
Acta Biomater; 2017 Mar; 50():127-141. PubMed ID: 27940194
[TBL] [Abstract][Full Text] [Related]
13. Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-diamminedichloroplatinum cisplatin on human ovarian cancer.
Tang Q; Chen D
Biomed Mater Eng; 2014; 24(1):711-22. PubMed ID: 24211956
[TBL] [Abstract][Full Text] [Related]
14. Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-
Hou Z; Gattoc L; O'Connor C; Yang S; Wallace-Povirk A; George C; Orr S; Polin L; White K; Kushner J; Morris RT; Gangjee A; Matherly LH
Mol Cancer Ther; 2017 May; 16(5):819-830. PubMed ID: 28138029
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
[TBL] [Abstract][Full Text] [Related]
16. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic activity of heparin functionalised cerium oxide nanoparticles.
Lord MS; Tsoi B; Gunawan C; Teoh WY; Amal R; Whitelock JM
Biomaterials; 2013 Nov; 34(34):8808-18. PubMed ID: 23942211
[TBL] [Abstract][Full Text] [Related]
18. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
19. Auricularia auriculajudae polysaccharide-cisplatin complexes conjugated with folic acid as new tumor targeting agents.
Qiu J; Zhang H; Wang Z
Int J Biol Macromol; 2018 Dec; 120(Pt A):966-974. PubMed ID: 29990555
[TBL] [Abstract][Full Text] [Related]
20. Folic acid conjugated magnetic iron oxide nanoparticles for nondestructive separation and detection of ovarian cancer cells from whole blood.
Liu W; Nie L; Li F; Aguilar ZP; Xu H; Xiong Y; Fu F; Xu H
Biomater Sci; 2016 Jan; 4(1):159-66. PubMed ID: 26478922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]